123 related articles for article (PubMed ID: 25635880)
1. Assessment of the olfactory function in Italian patients with type 3 von Willebrand disease caused by a homozygous 253 Kb deletion involving VWF and TMEM16B/ANO2.
Cenedese V; Mezzavilla M; Morgan A; Marino R; Ettorre CP; Margaglione M; Gasparini P; Menini A
PLoS One; 2015; 10(1):e0116483. PubMed ID: 25635880
[TBL] [Abstract][Full Text] [Related]
2. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
[TBL] [Abstract][Full Text] [Related]
3. Anoctamin 2/TMEM16B: a calcium-activated chloride channel in olfactory transduction.
Pifferi S; Cenedese V; Menini A
Exp Physiol; 2012 Feb; 97(2):193-9. PubMed ID: 21890523
[TBL] [Abstract][Full Text] [Related]
4. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
[TBL] [Abstract][Full Text] [Related]
6. Developmental expression of the calcium-activated chloride channels TMEM16A and TMEM16B in the mouse olfactory epithelium.
Maurya DK; Menini A
Dev Neurobiol; 2014 Jul; 74(7):657-75. PubMed ID: 24318978
[TBL] [Abstract][Full Text] [Related]
7. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
[TBL] [Abstract][Full Text] [Related]
8. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):111-8. PubMed ID: 19506357
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients.
Solimando M; Baronciani L; La Marca S; Cozzi G; Asselta R; Canciani MT; Federici AB; Peyvandi F
Am J Hematol; 2012 Sep; 87(9):870-4. PubMed ID: 22674667
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand Disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families.
Schneppenheim R; Federici AB; Budde U; Castaman G; Drewke E; Krey S; Mannucci PM; Riesen G; Rodeghiero F; Zieger B; Zimmermann R
Thromb Haemost; 2000 Jan; 83(1):136-40. PubMed ID: 10669167
[TBL] [Abstract][Full Text] [Related]
11. [Phenotype and genotype analysis of two Chinese pedigrees with type 3 von Willebrand diseases].
Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Wang HL; Xi XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):524-8. PubMed ID: 23042386
[TBL] [Abstract][Full Text] [Related]
12. A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions.
Xie F; Wang X; Cooper DN; Chuzhanova N; Fang Y; Cai X; Wang Z; Wang H
Blood Cells Mol Dis; 2006; 36(3):385-91. PubMed ID: 16690331
[TBL] [Abstract][Full Text] [Related]
13. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
Ahmad F; Kannan M; Biswas A; Saxena R
Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
[TBL] [Abstract][Full Text] [Related]
14. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
15. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin.
Eikenboom JC; Castaman G; Vos HL; Bertina RM; Rodeghiero F
Thromb Haemost; 1998 Apr; 79(4):709-17. PubMed ID: 9569178
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.
Lavergne JM; Piao Y; Ribba AS; Girma JP; Siguret V; Piétu G; Boyer-Neumann C; Schandelong A; Bahnak BR; Meyer D
Thromb Haemost; 1993 Oct; 70(4):691-6. PubMed ID: 8115998
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations identified in a type 3 von Willebrand disease patient.
Ouyang W; Yu Z; Yin J; Su J; Yang C; Ruan C
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):909-11. PubMed ID: 24914743
[TBL] [Abstract][Full Text] [Related]
20. The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.
Sutherland MS; Keeney S; Bolton-Maggs PH; Hay CR; Will A; Cumming AM
Haemophilia; 2009 Sep; 15(5):1048-57. PubMed ID: 19601990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
